| __timestamp | HUTCHMED (China) Limited | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 33472000 | 347523000 |
| Thursday, January 1, 2015 | 47368000 | 479514000 |
| Friday, January 1, 2016 | 66871000 | 581861000 |
| Sunday, January 1, 2017 | 50675000 | 1326361000 |
| Monday, January 1, 2018 | 78821000 | 1197957000 |
| Tuesday, January 1, 2019 | 91944000 | 1154111000 |
| Wednesday, January 1, 2020 | 111234000 | 2215942000 |
| Friday, January 1, 2021 | 207447000 | 1458179000 |
| Saturday, January 1, 2022 | 267587000 | 1585936000 |
| Sunday, January 1, 2023 | 303055000 | 1627594000 |
| Monday, January 1, 2024 | 2606848000 |
Infusing magic into the data realm
In the competitive world of biotechnology, innovation is the key to success. Incyte Corporation and HUTCHMED (China) Limited are two prominent players, each with a unique approach to research and development (R&D) investment. Over the past decade, Incyte has consistently outpaced HUTCHMED in R&D spending, investing nearly 10 times more on average. In 2020, Incyte's R&D expenses peaked at approximately $2.2 billion, a staggering 100% increase from 2014. Meanwhile, HUTCHMED's investment grew steadily, reaching around $303 million in 2023, marking a 900% increase since 2014. This significant growth highlights HUTCHMED's commitment to innovation, despite its smaller scale. As these companies continue to invest in groundbreaking research, their strategies offer valuable insights into the future of biotech innovation.
Analyzing R&D Budgets: Amgen Inc. vs HUTCHMED (China) Limited
Takeda Pharmaceutical Company Limited or HUTCHMED (China) Limited: Who Invests More in Innovation?
Biogen Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
BeiGene, Ltd. vs Incyte Corporation: Strategic Focus on R&D Spending
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
R&D Insights: How Incyte Corporation and Amneal Pharmaceuticals, Inc. Allocate Funds
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Incyte Corporation and Geron Corporation
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and BioCryst Pharmaceuticals, Inc.
Comparing Innovation Spending: Madrigal Pharmaceuticals, Inc. and HUTCHMED (China) Limited
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs HUTCHMED (China) Limited
Analyzing R&D Budgets: HUTCHMED (China) Limited vs Geron Corporation